Matches in Nanopublications for { ?s ?p "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP124962.RAV3bkWl9X8EgaeliGhqqKi8sAGgYn_cM1ya9W4ajcQn0130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124962.RAV3bkWl9X8EgaeliGhqqKi8sAGgYn_cM1ya9W4ajcQn0130_provenance.
- NP853423.RApbHuXn6q6nQVwVFciJta-6fkZXkDDor4wLbQ64Q89g4130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853423.RApbHuXn6q6nQVwVFciJta-6fkZXkDDor4wLbQ64Q89g4130_provenance.
- NP424966.RAm-pSnS55Wq_psJagsbO1ecZyuuSjfccpLv4_cyIf-M4130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424966.RAm-pSnS55Wq_psJagsbO1ecZyuuSjfccpLv4_cyIf-M4130_provenance.
- NP124950.RAye50c3d3tgBeiBAucgt_pjrys6JflDl3V2J8Ts6e-3I130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124950.RAye50c3d3tgBeiBAucgt_pjrys6JflDl3V2J8Ts6e-3I130_provenance.
- assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP188146.RAdk2D8Q5a4dqdGeA0BNebAZYgS-iiM0IPRmJ5c28CLIY130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188146.RAdk2D8Q5a4dqdGeA0BNebAZYgS-iiM0IPRmJ5c28CLIY130_provenance.
- NP907958.RAZJLuBQBJKFUbOHnm58hLfhuiPl1VdfYFiH0VrkuOTew130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907958.RAZJLuBQBJKFUbOHnm58hLfhuiPl1VdfYFiH0VrkuOTew130_provenance.
- assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618368.RASXIslXbUZm-nK8_rNFkd3Cs1gB1TmU3G4svoMX7XwS8130_provenance.
- NP339045.RAlclrQvy4rY8haU78pG-vIQytqhaTMATb67oCmpKYqdc130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339045.RAlclrQvy4rY8haU78pG-vIQytqhaTMATb67oCmpKYqdc130_provenance.
- NP226826.RAg9V7E_9exFhTaur17MMhtGb9hsEHcPF88u8JuOK97Qc130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226826.RAg9V7E_9exFhTaur17MMhtGb9hsEHcPF88u8JuOK97Qc130_provenance.
- NP188134.RALSdq6kE0YAqGK72REXppJg0L5evtcAcF4dOPgLGyKD4130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188134.RALSdq6kE0YAqGK72REXppJg0L5evtcAcF4dOPgLGyKD4130_provenance.
- NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226827.RAPaykIlD_EmNWIyRBSQaxK-rZ-OXWme_aVcuSJdOrHlc130_provenance.
- NP618369.RANzsnBCfmeZghthpFVVSfBPrO4I7oKfbyH-736rPHCr8130_assertion description "[Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618369.RANzsnBCfmeZghthpFVVSfBPrO4I7oKfbyH-736rPHCr8130_provenance.